Strong Independent Association of TILs with OS for Patients with ERBB2-positive Early Breast Cancer By Ogkologos - February 26, 2025 730 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from updated analysis of the ShortHER study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism MOST POPULAR Saving Time for Patients and Improving Well-Being Through Mindfulness and Fitness:... October 23, 2023 Combination Therapy for Metastatic Prostate Cancer Helps Some Men Live Longer March 11, 2025 Women in Science: Celebrating with our Women of Influence initiative March 15, 2023 ESMO Announces Results of 2025 Elections June 14, 2025 Load more HOT NEWS Androgen Receptor May Explain Sex Differences in Melanoma Treatment Response Nivolumab vs Sorafenib in First-Line Treatment of Advanced Hepatocellular Carcinoma Better EFS Outcomes with Perioperative Durvalumab Plus FLOT Than with Placebo... Thank you!
